Mechanism of interventional effect and targets of Zhuyu pill in regulating and suppressing colitis and cholestasis

Mechanism of interventional effect and targets of Zhuyu pill in regulating and suppressing colitis and cholestasis

Zhuyu pill (ZYP) is a traditional Chinese medicine prescription composed of two drugs, Coptis chinensis Franch. and Tetradium ruticarpum (A. Jussieu) T. G. Hartley, and is commonly used in the clinical treatment of diseases of the digestive system. However, the mechanism underlying the effect of ZYP...

Full description

Bibliographic Details
Main Authors:	Han Yu, Fenghua Zhang, Yueqiang Wen, Zhili Zheng, Gaoyang Chen, Yingying Pan, Peijie Wu, Qiaobo Ye, Jun Han, Xiaofeng Chen, Chao Liu, Tao Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Pharmacology
Subjects:	cholestasis colitis common interventional mechanism fecal microbial diversity fecal metabolism Zhuyu pill
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1038188/full

Similar Items

Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity
by: Han Yu, et al.
Published: (2021-09-01)

The zhuyu pill relieves rat cholestasis by regulating the mRNA expression of lipid and bile metabolism associated genes
by: Jun Han, et al.
Published: (2023-10-01)

Effects and Potential Mechanism of Zhuyu Pill Against Atherosclerosis: Network Pharmacology and Experimental Validation
by: Pan Y, et al.
Published: (2023-02-01)

Study on quality control methods of Shaofu Zhuyu pills
by: Liyao SHI, et al.
Published: (2019-06-01)

Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis
by: Jinxia Yuan, et al.
Published: (2022-12-01)

Norethisterone‐induced cholestasis: A case report
by: Safa Moussaoui, et al.
Published: (2022-03-01)

XuefuZhuyu decoction protected cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy
by: Xiaowen Shi, et al.
Published: (2017-06-01)

Fecal microbiota transplantation for recurrent infection in a patient with ulcerative colitis
by: Kosaku Nanki, et al.
Published: (2018-01-01)

Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?
by: Ajit Sood, et al.
Published: (2022-07-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study
by: Avnish Kumar Seth, et al.
Published: (2022-04-01)

A Chinese classical prescription Xuefu Zhuyu decoction in the treatment of coronary heart disease: An overview
by: Xuezhen Wang, et al.
Published: (2024-04-01)

A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
by: Gonzalo Hijos-Mallada, et al.
Published: (2021-12-01)

Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance
by: Chunlan Huang, et al.
Published: (2022-06-01)

Ischemic colitis complicated by infection treated with fecal microbiota transplantation
by: Seok Hyung Kang, et al.
Published: (2023-09-01)

Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy
by: Oleg V. Knyazev, et al.
Published: (2021-12-01)

Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease
by: Bin Liang, et al.
Published: (2020-12-01)

Stercoral colitis mimicking appendicitis
by: Abdelghafour Elkoundi, et al.
Published: (2017-02-01)

Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis
by: Zhenhua Wu, et al.
Published: (2021-09-01)

Effect of disease duration on fecal biomarkers in ulcerative colitis: a prospective cohort study
by: Natsuki Ishida, et al.
Published: (2022-09-01)

Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer
by: Yuji Fujita, et al.
Published: (2021-11-01)

The mechanisms underlying the actions of Xuefu Zhuyu decoction pretreatment against neurological deficits after ischemic stroke in mice: The mediation of glymphatic function by aquaporin-4 and its anchoring proteins
by: Ting Yi, et al.
Published: (2022-12-01)

Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
by: Shinta Mizuno, et al.
Published: (2017-01-01)

Incidental benefits after fecal microbiota transplant for ulcerative colitis
by: Ramit Mahajan, et al.
Published: (2020-07-01)

Analysis of the Anti-Tumour Effect of Xuefu Zhuyu Decoction Based on Network Pharmacology and Experimental Verification in Drosophila
by: Sitong Wang, et al.
Published: (2022-07-01)

Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative Colitis
by: Xiaochen Zhang, et al.
Published: (2022-02-01)

Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients (CheruPDYS): a study protocol for a randomized placebo-controlled trial
by: Geng Li, et al.
Published: (2021-01-01)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
by: Chunlan Huang, et al.
Published: (2022-08-01)

Regulatory Effect of Sishen Pill on Tfh Cells in Mice With Experimental Colitis
by: Xue-Ke Liu, et al.
Published: (2020-06-01)

Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews
by: Haixia Liu, et al.
Published: (2023-11-01)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
by: von Arnim U, et al.
Published: (2016-04-01)

Taxifolin Alleviates DSS-Induced Ulcerative Colitis by Acting on Gut Microbiome to Produce Butyric Acid
by: Wei Li, et al.
Published: (2022-03-01)

Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study
by: Onişor Danusia, et al.
Published: (2018-07-01)

Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis
by: Hiroaki Kitae, et al.
Published: (2022-05-01)

Bioinformatics Analysis of miRNAs and mRNAs Network-Xuefu Zhuyu Decoction Exerts Neuroprotection of Traumatic Brain Injury Mice in the Subacute Phase
by: Zhao-yu Yang, et al.
Published: (2022-06-01)

Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study
by: Yan Tian, et al.
Published: (2019-07-01)

The anti-cholestatic effects of Coptis chinensis Franch. alone and combined with Tetradium ruticarpum (A. Jussieu) T. G. Hartley: dual effects on fecal metabolism and microbial diversity
by: Jun Han, et al.
Published: (2024-03-01)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
by: Loris Riccardo Lopetuso, et al.
Published: (2023-10-01)

Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series
by: Xiao-Fei Dang, et al.
Published: (2020-11-01)

Fecal B-cell-activating factor as a new noninvasive marker in the evaluation of ulcerative colitis Egyptian patients: a comparative cross-sectional study
by: Hany A Hussein, et al.
Published: (2019-01-01)